


The Nano-bio-technology Hub Revenue
Biotechnology Research ⢠Alderley Park, Nether Alderley, United Kingdom ⢠1-10 Employees
The Nano-bio-technology Hub revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at The Nano-bio-technology Hub
Alfredo Maria Gravagnuolo
Company Director
Company overview
| Headquarters | Alderley Park, Nether Alderley, England SK10 4JS, GB |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Mos2, Medical Devices, Healthcare, Networking, Product Development, Graphene, Nanoparticles, Nanomaterials, In Vitro Diagnostics, Cardiovascular, Biomaterials, 2D Materials, Point Of Care, Nanobiotechnology, Antimicrobial Resistance, Gold Nanoparticles, Lateral Flow, Advanced Functional Materials, Nano-Biomaterials |
| Founded | 2025 |
| Employees | 1-10 |
About The Nano-bio-technology Hub
š The Nano-bio-technology Hub Ltd is a cutting edge start up transforming cardiovascular diagnostics with breakthrough, optically active nano-biomaterials, integrated into next-gen medical devices. The vision is rooted in the challenges that founder Dr. Alfredo M. Gravagnuolo has been navigating since 2020, while developing and validating in vitro diagnostics across both private and public sectors. š¬ Decentralise healthcare for a sustainable ageing society. By powering lateral flow and other rapid point-of-care diagnostics with ultra performing nano-biomaterials, we bring hospital grade performance out of the clinic and into peopleās hands, reliable, affordable, and fast. Miniaturising hospital equipment: our nanotechnology ensures the same gold standard accuracy, but at low cost and high speed. š” Our mission is to decentralise cardiovascular diagnostics. As proof of concept, we are developing portable, ultra sensitive acute cardiovascular tests for use in ambulances. A negative result enables safe triage and early discharge, conserving resources and for peace of mind on the go. A positive result flags urgent intervention, where every minute matters to avoid further damage to cardiac tissue and other organs, and chronic follow up. š Beyond diagnostics, The Nanobiotechnology Hub is a community of innovators bringing together experts in nano-bio-technology, NGS, drug delivery, and sustainability for powerful collaborations. ⨠Weāre unlocking a new era of decentralised, participatory healthcare.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
The Nano-bio-technology Hub has never raised funding before.
Frequently asked questions
4.8
40,000 users



